Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: Ann Arbor, MI MSA — September 2026
Ann Arbor life sci talent tightens even as metro jobs shrink.
Washtenaw County unemployment held at 4.2% despite the Ann Arbor MSA's -2.3% June employment drop, while Biostatistician pay climbed to a $156,868 metro median against $133,322 nationally.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- Washtenaw unemployment rate: 4.2% — Unchanged from July 2026
- Ann Arbor MSA employment change: -2.3% — Steepest monthly drop among Michigan metros, June 2026
- Biostatistician advertised pay (metro): $156,868 — vs $133,322 national median
- Washtenaw avg weekly wage: $1,323+ — Above Michigan state average, Q3 2025
Key takeaways
Ann Arbor's job losses are concentrated, not systemic.
The metro's -2.3% monthly employment drop in June was the sharpest among Michigan metros, yet unemployment held flat at 4.2% and wages above state average — consistent with layoffs hitting specific sectors rather than life sciences broadly. Treat this as a signal to monitor sector-specific WARN activity rather than assume easier access to talent across the board.
Regulatory Affairs pay is falling locally while the national market tightens.
Metro Regulatory Affairs Specialist pay dropped significantly to a $95,340 median even as national demand for regulatory leadership intensifies amid EU MDR and FDA pathway shifts, with VP-level roles nationally commanding $320K-$580K. This divergence may reflect fewer senior regulatory postings locally rather than true pay softening — worth validating before assuming Ann Arbor offers a regulatory talent discount.
Clinical Research Associate pay is pulling sharply away from national trend.
Metro CRA pay fell to a $51,137 median while the national median climbed to $90,956, a gap wide enough to suggest local postings skew toward junior or academic-affiliated roles rather than full clinical trial capacity. Organizations benchmarking CRA compensation locally should weight national data more heavily if competing for experienced clinical operations talent against CROs.
Biostatistics premium reflects where scarcity is concentrated.
Metro Biostatistician pay rose to $156,868, well above the $133,322 national median, tracking the University of Michigan's research density and the broader national bottleneck in pharmacometrics and biostatistics talent. Expect this premium to persist as data science and biostatistics headcount planning competes directly with academic and adjacent research institution demand.
Median advertised pay by role — Ann Arbor, MI MSA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $95,062 | $133,986 | $152,750 | Significant increase | $131,354 |
| Clinical Research Associate | $47,504 | $51,137 | $57,055 | Moderate decline | $90,956 |
| Lab Technician | $36,866 | $40,702 | $41,232 | Moderate increase | $47,402 |
| Regulatory Affairs Specialist * | $68,607 | $95,340 | $114,031 | Significant decline | $104,000 |
| Clinical Data Manager * | $97,759 | $128,800 | $150,000 | Significant decline | $123,031 |
| Biostatistician | $126,096 | $156,868 | $156,868 | Significant increase | $133,322 |
| Validation Engineer * | $77,591 | $100,880 | $110,300 | Stable | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Washtenaw County's unemployment rate held at 4.2% in August, unchanged from July, even as the Ann Arbor MSA posted the steepest over-the-month employment decline of any Michigan metro at -2.3% in June — a divergence that points to selective, role-specific contraction rather than broad-based softening. Average weekly wages in the county continue to outpace the Michigan state average, with Q3 2025 figures exceeding $1,323 and employment still rising even as other high-wage counties shed jobs, suggesting the local labor market is tightening around a narrower band of specialized roles rather than loosening across the board.
What it means
Metro-level softness paired with sustained wage premiums signals a bifurcated market: routine and administrative life sciences functions may see easing pressure, while scientific, regulatory, and biostatistics talent anchored to University of Michigan-adjacent research infrastructure remains scarce and commands continued pay growth, as reflected in Biostatistician pay rising to a $156,868 metro median against $133,322 nationally. Build-vs-outsource tradeoffs for CMC and clinical operations capacity should account for this divergence — the metro's overall employment decline does not translate into easier access to credentialed scientific and regulatory staff. Consider reviewing headcount plans function-by-function rather than applying a single metro-wide hiring posture, since aggregate labor market loosening masks continued tightness in the roles most critical to pipeline execution.
Looking ahead
Worth watching: June's -2.3% employment drop in the Ann Arbor MSA warrants tracking into Q4 data to confirm whether it reflects a one-time contraction or the start of a sustained slide, particularly given Michigan's broader manufacturing-led WARN activity.
Emerging pressure point: Michigan's BioWorkforce Apprenticeship Program funding request signals state-level recognition of a manufacturing and quality talent gap; watch whether any Washtenaw-based biomanufacturers tap this pipeline before committing to CDMO partnerships for scale-up.
Early indicator: National September layoff announcements at BioMarin and Bristol Myers coexist with 64% of surveyed biopharma firms still actively recruiting — watch whether any released talent from these restructurings surfaces in the Ann Arbor candidate pool given the metro's research density.
Potential inflection point: Washtenaw County's projected payroll growth of just 0.2% for 2026 suggests headcount expansion will be selective; monitor whether life sciences employers continue prioritizing regulatory, biostatistics, and CMC roles while holding flat elsewhere.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.